Cargando…
p63 as a prognostic marker for giant cell tumor of bone
BACKGROUND AND PURPOSE: Giant cell tumor of bone (GCT) is sometimes difficult to distinguish from other giant-cell-rich tumors such as chondroblastoma (CHB) and aneurysmal bone cyst (ABC). The usefulness of p63 as a diagnostic marker for GCT is controversial. While there have been no reports about p...
Autores principales: | Yanagisawa, Michiro, kakizaki, Hiroshi, Okada, Kyoji, Torigoe, Tomoaki, Kusumi, Tomomi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Informa Healthcare
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3572666/ https://www.ncbi.nlm.nih.gov/pubmed/23033898 http://dx.doi.org/10.3109/03009734.2012.724731 |
Ejemplares similares
-
A clinicopathological study of giant cell tumor of small bones
por: Yanagisawa, Michiro, et al.
Publicado: (2011) -
Can p63 serve as a biomarker for giant cell tumor of bone? A Moroccan experience
por: Hammas, Nawal, et al.
Publicado: (2012) -
Utility of P63 in Differentiating Giant Cell Tumor from Other Giant Cell-Containing Lesions
por: Hui, Monalisa, et al.
Publicado: (2022) -
p63 regulates cell proliferation and cell cycle progression-associated genes in stromal cells of giant cell tumor of the bone
por: LAU, CAROL PO YING, et al.
Publicado: (2012) -
Can p63 serve as a biomarker for diagnosing giant cell tumor of bone? A systematic review and meta-analysis
por: Wan, Zihao, et al.
Publicado: (2020)